GSK Seeking Up to $2B Bolt-on Acquisitions in India
October 04, 2011 at 11:28 AM EDT
GlaxoSmithKline is looking to complete “smaller” acquisition targets in India in the $500 million to $2 billion range, according to the company’s CEO Andrew Witty. He characterized these transactions as bolt-on additions rather than transformative ones. GSK does not need a large acquisition, he said, because the company already has a well-established presence in India with a recognizable brand name. His comments would seem to apply equally to China, where GSK has been involved in several "smaller" M&A transactions. More details.... Stock Symbol: (NYSE: GSK) Share this with colleagues: